UK markets open in 4 hours 1 minute

Euroapi S.A. (0EAP.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
15.86+0.25 (+1.57%)
At close: 08:22AM BST
Full screen
Loading interactive chart…
  • Globe Newswire

    EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1

    Press Release Agreement with Sanofi on a 200 M€ investment through a Perpetual Subordinated Hybrid Bond, upon the completion of the ongoing discussions to amend and extend the current Revolving Credit Facility75 to 80 M€ annual run-rate incremental Core EBITDA targeted by the end of 2027, driven by the end of higher value API and CDMO offering, a streamlined industrial footprint, and significant cost reductions Brindisi site expected to progressively resume shipments and production during Q3 202

  • GlobeNewswire

    EUROAPI and Priothera enter into CDMO collaboration to advance oncology project

    Press Release EUROAPI and Priothera, a biotechnology company specializing in the treatment of hematological malignancies and the improvement of CAR-T cell therapies, have signed a 5-year CDMO agreementEUROAPI will develop and industrialize the manufacturing process of innovative complex molecule for blood cancers Paris – June 18, 2024 – EUROAPI announces today the implementation of a 5-year development and manufacturing agreement with Priothera, a biotechnology company specializing in molecules

  • Globe Newswire

    Market update : FOCUS-27 transformation project financing

    Press release Paris – June 6, 2024 – EUROAPI informs that it has decided to be assisted by a mandataire ad hoc in its discussions initiated in February 2024 regarding the mid-term and long-term financing of its FOCUS-27 strategic transformation project. The mandat ad hoc is an amicable procedure launched at the company's initiative and conducted within a confidential and legally secured framework. EUROAPI has appointed such an independent third party proactively to accelerate the outcome of the